Drug sensitivity testing for clinical samples from oesophageal cancer using adhesive tumour cell culture system
1996

Drug Sensitivity Testing for Oesophageal Cancer

Sample size: 78 publication Evidence: moderate

Author Information

Author(s): M Terashima, K Hayashi, M Fukushima, H Ide, T Iizuka, T Kakegawa, N Ando, O Tanaka, M Shinoda, K Isono, K Ishida, S Ikeuchi, M Endo, W Takiyama, T Yanagawa

Primary Institution: Japanese Esophageal Oncology Group

Hypothesis

Can the adhesive tumour cell culture system effectively test drug sensitivity in oesophageal cancer patients?

Conclusion

The adhesive tumour cell culture system is a clinically applicable method for testing drug sensitivity in oesophageal cancer.

Supporting Evidence

  • 71 out of 83 specimens had enough cells to grow in culture.
  • 57 of the 71 specimens were evaluable for drug response.
  • The population distribution of IC90 values showed specific patterns among different drugs.
  • The study achieved a high evaluability rate of 83%.
  • The in vitro AUC of the 10th percentile of IC90 values correlated well with previously reported in vivo AUCs.

Takeaway

Doctors can use a special test to see how well cancer drugs work on a patient's oesophageal cancer before giving them treatment.

Methodology

The study involved culturing cancer cells from surgically resected tumours and testing their sensitivity to various drugs using the adhesive tumour cell culture system.

Limitations

The study had some unevaluable assays due to low growth, overgrowth, and contamination.

Participant Demographics

Patients with squamous cell carcinoma of the oesophagus from 11 institutes.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication